| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 4, 2025 | Dec 8, 2025 | Bioventus Inc. | Director | Sell | 22.5 | -10,000 | -7.90% | ✗ | $75.7K |
| Dec 28, 2015 | Dec 30, 2015 | Evofem Biosciences, Inc. | Other | Sell | 17.5 | -797,987 | -37.33% | ✗ | $1.2M |
| Dec 15, 2015 | Dec 17, 2015 | Evofem Biosciences, Inc. | 10% Owner | Sell | 20.0 | -529,261 | -19.84% | ✗ | $762.1K |
| Apr 14, 2015 | Apr 14, 2015 | KalVista Pharmaceuticals, Inc. | Director | Buy | 100.0 | +877,500 | 25.32% | ✗ | $4.4M |
| Nov 25, 2014 | Nov 25, 2014 | Evofem Biosciences, Inc. | 10% Owner | Sell | 27.5 | -79,286 | -0.76% | ✗ | $1.1M |
| Oct 21, 2014 | Oct 21, 2014 | Esperion Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +500,000 | 24.36% | ✗ | $10M |
| Sep 19, 2013 | Sep 23, 2013 | TALPHERA, INC. | Director | Sell | 27.5 | -158,153 | -5.93% | ✓ | $1.7M |
| Sep 16, 2013 | Sep 18, 2013 | TALPHERA, INC. | Director | Sell | 32.5 | -128,780 | -4.61% | ✓ | $1.3M |
| Jul 1, 2013 | Jul 1, 2013 | Esperion Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +235,714 | 12.98% | ✗ | $3.3M |
| Feb 16, 2011 | Feb 18, 2011 | TALPHERA, INC. | Director | Buy | 100.0 | +680,000 | 32.15% | ✗ | $3.4M |
| Feb 16, 2011 | Feb 18, 2011 | TALPHERA, INC. | Director | Buy | 100.0 | +680,000 | 32.15% | ✗ | $3.4M |